Legal 500
Log in or register
  • Rankings

    • Jurisdictions
    • Submissions
    • Future Lawyers
  • Firms & Lawyers

    • Service Providers
    • Barristers’ Sets
    • Networks
    • Interview with…
  • In-House

    • In-House Content
    • GC Powerlist
  • Knowledge Centre

    • Data Products
    • Legal Business
    • Market Intelligence
    • About us

      • Legal 500
      • FAQs
      • Marketing
      • Careers
      • Trust Centre
      • Contact us
  • Comparative Guides
  • Events
  • Legal 500 TV

About us

  • Legal 500
  • FAQs
  • Marketing
  • Careers
  • Trust Centre
  • Contact us
  • Deutschland DE
  • Paris FR
  • Rankings

    • Jurisdictions
    • Submissions
    • Future Lawyers
  • Firms & Lawyers

    • Service Providers
    • Barristers’ Sets
    • Networks
    • Interview with…
  • In-House

    • In-House Content
    • GC Powerlist
  • Knowledge Centre

    • Data Products
    • Legal Business
    • Market Intelligence
    • About us

      • Legal 500
      • FAQs
      • Marketing
      • Careers
      • Trust Centre
      • Contact us
  • Comparative Guides
  • Events
  • Legal 500 TV

About us

  • Legal 500
  • FAQs
  • Marketing
  • Careers
  • Trust Centre
  • Contact us
  • Deutschland DE
  • Paris FR

© 2026 Legalease Ltd. All rights reserved

Registered company in England & Wales No. 02427356 VAT GB 321 5727 22

Registered address: 188 Fleet Street, London, EC4A 2AG

  • Legal 500 Trust Centre
  • Contact Us
  • home
  • Market Intelligence
  • Search

22,543 results found

Use advanced search filters to refine your search

2 filters applied

Advanced search filters

Topics
Countries
Contributor

Start typing to add contributors

Content type
Show options
  • Article

    Computerized Price Quote Patent Held Invalid Under §101

    Alice is clear that inventions drawn to automating well-known concepts are not patent-eligible.
    United StatesIntellectual Property
    Seyfarth Shaw LLP
    Seyfarth Shaw LLP
  • Article

    Conflicting Prosecution Statements Can Render Claims Indefinite

    The district court held that because of the inconsistent positions in the intrinsic record, the claims reciting this term were indefinite.
    United StatesIntellectual Property
    Finnegan, Henderson, Farabow, Garrett & Dunner LLP
    Finnegan, Henderson, Farabow, Garrett & Dunner LLP
Article

D. Mass. Patent Litigation Update, September 2023

This is part of a series of articles discussing recent orders of interest issued in patent cases by the United States District Court for the District of Massachusetts.
United StatesIntellectual Property
Finnegan, Henderson, Farabow, Garrett & Dunner LLP
Finnegan, Henderson, Farabow, Garrett & Dunner LLP
  • Article

    Deal On IP Rights For Biologic Drugs Under TPP Close

    According to industry and congressional sources, a deal on intellectual property rights for biologic drugs under the TPP may be in the near future.
    United StatesIntellectual Property
    Jones Day
    Jones Day
  • Article

    December Issue Of The Bio/Pharma Beat Is Now Available!

    Our monthly newsletter reports on the patent law developments in biotech, biologics and pharmaceutical cases, legislation and federal agency actions.
    United StatesIntellectual Property
    Squire Patton Boggs LLP
    Squire Patton Boggs LLP
  • Video

    Discussing The Supreme Court's Oral Arguments In Myriad Gene Patenting Case (Video Content)

    Earlier this week, I had the opportunity to speak again with Colin O'Keefe of LXBN regarding last week's oral arguments in Association for Molecular Pathology v. Myriad Genetics.
    United StatesIntellectual Property
    Foley & Lardner LLP
    Foley & Lardner LLP
  • Article

    Does Arthrex Matter?

    Arthrex grabbed headlines, but will it actually be a useful tool for PTAB oversight.
    United StatesIntellectual Property
    Winston Taylor
    Winston Taylor
  • Article

    Don’t Buy Someone Else’s IP Problem

    Intellectual property due diligence often gets relegated to a final checklist item in acquisitions, but this approach can lead to costly oversights. Jason Balich explores why IP assessment should receive the same early, strategic attention as financial analysis, and provides a framework for evaluating whether a target company's patents, trademarks, and trade secrets are properly secured and enforceable.
    United StatesIntellectual Property
    Wolf Greenfield & Sacks
    Wolf Greenfield & Sacks
  • Article

    Failure To Make IPR Declarant Available For Deposition May Result In Exclusion, PTAB Litigation Blog

    Although this seems pretty obvious, failure to make an IPR declarant available for deposition likely will cause the Board to exclude the declarant's testimony from the trial, absent agreement...
    United StatesIntellectual Property
    Jones Day
    Jones Day
  • Article

    FDA Determines Regulatory Review Periods For Three Drug Patents

    In recent issues of the Federal Register, FDA announced determinations of the regulatory review periods for extension of three drug patents.
    United StatesIntellectual Property
    Jones Day
    Jones Day
  • Article

    Fed. Cir. Rejects New IPR Constitutional Challenges

    In Mobility Workx, LLC v. Unified Patents, LLC, the Federal Circuit in a split decision concluded that Mobility Workx, LLC's constitutional challenges to structure and funding of the Patent Trial...
    United StatesIntellectual Property
    Jones Day
    Jones Day
  • Article

    Federal Circuit Affirms Invalidity Challenge To Scientifically Impossible Claim Language On Enablement Grounds

    The Federal Circuit affirmed invalidity of a patent claiming transmission of electric signals over air—a scientifically impossible feat—but diverged from the lower court by basing its decision on enablement rather than indefiniteness grounds. This case explores the critical distinction between claim definiteness and enablement under 35 U.S.C. § 112, particularly when patent claims encompass scientifically impossible embodiments.
    United StatesIntellectual Property
    Finnegan, Henderson, Farabow, Garrett & Dunner LLP
    Finnegan, Henderson, Farabow, Garrett & Dunner LLP
  • Article

    Federal Circuit Cautions Against Omitting Preamble Transition Words In Claim Drafting

    In Acceleration Bay, LLC v. Activision Blizzard Inc., the Federal Circuit affirmed the PTAB's holding that certain claims of patents owned by Acceleration Bay were unpatentable ...
    United StatesIntellectual Property
    Finnegan, Henderson, Farabow, Garrett & Dunner LLP
    Finnegan, Henderson, Farabow, Garrett & Dunner LLP
  • Article

    Federal Circuit Clarifies Meaning Of "Consisting Essentially Of"

    In this case, the Federal Circuit held that, depending on context such as prosecution history, amending patent claims to use the transitional phrase...
    United StatesIntellectual Property
    Lerner David Littenberg Krumholz & Mentlik, LLP
    Lerner David Littenberg Krumholz & Mentlik, LLP
  • Article

    Federal Circuit Clarifies Prior Art Effective Date Relative To Provisional

    The Federal Circuit recently vacated a PTAB decision in Dental Monitoring SAS v. Align Technology, Inc., addressing a critical question about prior art qualification under the America Invents Act.
    United StatesIntellectual Property
    Jones Day
    Jones Day
  • Article

    Federal Circuit Finds PTAB Should Have Invalidated Additional Claims In IPRs

    In CRFD Research, Inc. v. Matal, No. 2016-2198 (Fed. Cir. Dec. 5, 2017), the Federal Circuit reviewed three IPR decisions, each on the same patent, reversing the PTAB's finding in one of the three decisions.
    United StatesIntellectual Property
    Finnegan, Henderson, Farabow, Garrett & Dunner LLP
    Finnegan, Henderson, Farabow, Garrett & Dunner LLP
  • Article

    Federal Circuit - Non-Naturally DNA Patent-Eligible

    Today, in Ass’n for Molecular Pathology v. Myriad Genetics, Inc., No. 2010-1406 (Fed. Cir. 2012), the Federal Circuit held that non-naturally occurring DNA is patent eligible as well as the use of a transformed, non-naturally occurring cell for screening drug candidates.
    United StatesIntellectual Property
    Foley & Lardner LLP
    Foley & Lardner LLP
  • Article

    Federal Circuit Preserves Plaintiff's Choice Of Forum In Hatch-Waxman Cases

    Intellectual Property special counsel Christine Willgoos and associate Shannon H. Hedvat's article "Federal Circuit Preserves Plaintiff's Choice of Forum in Hatch-Waxman Cases," appeared in the May/June 2016 issue of IP Litigator.
    United StatesIntellectual Property
    Herbert Smith Freehills Kramer LLP
    Herbert Smith Freehills Kramer LLP
  • Article

    Federal Circuit Reverses Indefiniteness Ruling On Means-Plus-Function Claim

    The Federal Circuit reversed a district court's indefiniteness ruling on a means-plus-function limitation, finding that the specification adequately disclosed corresponding structure for a "control means" term. The appellate court held that the district court improperly required the disclosed structure to perform unclaimed functions and incorrectly applied the algorithm disclosure requirement to logic circuitry-based controllers.
    United StatesIntellectual Property
    Finnegan, Henderson, Farabow, Garrett & Dunner LLP
    Finnegan, Henderson, Farabow, Garrett & Dunner LLP
  • Article

    Firing Up The Imagination (Podcast)

    Michael and Colin discuss fire pits, problem solving as a key feature of inventing, and perseverance with solo entrepren-eer, John Chadwell.
    United StatesIntellectual Property
    Perkins Coie LLP
    Perkins Coie LLP
  • Showing 341–360 of 22543 results

    PreviousNext
    Legal Intelligence Newsletters: sign up for the latest legal and regulatory news on your chosen topics